Daniel P. Gold Phd - May 25, 2021 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Signature
/s/ Brian G. Drazba, as attorney in fact
Stock symbol
MEIP
Transactions as of
May 25, 2021
Transactions value $
$12,600
Form type
4
Date filed
5/27/2021, 01:35 PM
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEIP Common Stock Options Exercise $12.6K +5K +1.1% $2.52 459K May 25, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Options Exercise $0 -5K -0.74% $0.00 675K May 25, 2021 Common Stock 5K $2.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.
F2 306,667 of the options are fully vested and currently exercisable. The remaining 368,333 options will vest in equal monthly installments through July 1, 2023.